"Atenolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
Descriptor ID |
D001262
|
MeSH Number(s) |
D02.033.100.624.698.070 D02.033.755.624.698.070 D02.092.063.624.698.070
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Atenolol".
Below are MeSH descriptors whose meaning is more specific than "Atenolol".
This graph shows the total number of publications written about "Atenolol" by people in this website by year, and whether "Atenolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 1 | 2 |
2018 | 0 | 1 | 1 |
2019 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Atenolol" by people in Profiles.
-
Pharmacological modulation of b-adrenoceptors as a new cardioprotective strategy for therapy of myocardial dysfunction induced by ischemia and reperfusion. Acta Cir Bras. 2019; 34(5):e201900505.
-
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis. J Hypertens. 2019 04; 37(4):844-850.
-
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis. Emerg Med J. 2018 Sep; 35(9):559-563.
-
Facile formation of co-amorphous atenolol and hydrochlorothiazide mixtures via cryogenic-milling: Enhanced physical stability, dissolution and pharmacokinetic profile. Int J Pharm. 2017 Oct 30; 532(1):393-400.
-
Beta-blockers for hypertension. Cochrane Database Syst Rev. 2017 01 20; 1:CD002003.